Deracoxib is a prescription veterinary NSAID used in dogs for osteoarthritis pain and selected post-operative pain. It belongs to the coxib group and is designed to favor COX-2 inhibition, but that does not make it harmless. Gastrointestinal ulceration, kidney injury and other adverse effects remain possible, particularly with dehydration, overdose, concurrent steroids or another NSAID.
Dog Medication Math Calculator
Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.
Dose information from your veterinarian
Optional liquid conversion

This guide explains how deracoxib fits among canine NSAIDs, why osteoarthritis and surgical pain may use different treatment plans, what adverse effects owners should recognize, how kidney and liver health affect safety, why switching between NSAIDs requires planning, and why sudden pain worsening should trigger reassessment rather than unsupervised dose changes.
What deracoxib is
Deracoxib is a coxib NSAID that reduces prostaglandin-mediated pain and inflammation through preferential COX-2 inhibition.
What COX-2 preference means
COX-2 is strongly associated with inflammatory prostaglandin production, while COX-1 supports several protective physiologic functions.
Why selectivity is not absolute
At therapeutic or higher exposures, clinically important GI and renal adverse effects remain possible.
Common veterinary uses
Deracoxib may be used for osteoarthritis pain and selected surgical pain according to approved labeling and the veterinarian’s judgment.
Why arthritis treatment is long-term management
Medication should be combined with weight control, controlled exercise, rehabilitation and home adaptation. See Arthritis in Dogs.
Why post-operative pain is different
Surgical pain is acute and changes rapidly over days, so the treatment plan may include opioids, local anesthetics or other analgesics in addition to or instead of an NSAID.
Why one NSAID should not be judged only by how sleepy the dog is
NSAIDs are not sedatives. A dog can have good pain relief while remaining fully alert.
Why dogs respond differently to individual NSAIDs
Clinical benefit and GI tolerance vary among patients despite broadly similar mechanisms.
Why deracoxib is not simply a higher- or lower-strength version of carprofen
They are different molecules with different pharmacology and cannot be compared by tablet milligrams alone.
Why milligram numbers are misleading between drugs
Each drug has its own potency and labeled exposure, so a 25 mg tablet of one NSAID cannot be compared directly with 25 mg of another.
Deracoxib dosage by weight: arthritis and postoperative regimens differ
The FDA-approved Deramaxx label uses different dose ranges for different indications. Osteoarthritis is labeled at 1–2 mg/kg once daily, while postoperative orthopedic pain uses 3–4 mg/kg once daily for no more than 7 days. Dental postoperative pain uses 1–2 mg/kg once daily for 3 days.
| Indication | FDA-labeled canine dose | Duration context |
|---|---|---|
| Osteoarthritis | 1–2 mg/kg once daily | As needed under veterinary monitoring |
| Orthopedic postoperative pain | 3–4 mg/kg once daily | Not to exceed 7 days at this dose |
| Dental postoperative pain | 1–2 mg/kg once daily | 3 days |
See the current FDA Deramaxx label. This indication-specific split is exactly why one generic “Deramaxx dose chart” can be misleading.
How deracoxib is given
Deramaxx is supplied as veterinary chewable tablets. Owners should give only the prescribed tablet strength and interval; the FDA label specifically warns against trying to create very small doses by breaking larger tablets inaccurately.
Why flavored tablets need secure storage
Dogs can consume an entire bottle if they regard the tablets as treats.
Can deracoxib be given with food?
It is often administered with food for tolerance depending on product instructions, but food does not prevent all adverse effects.
Why a meal does not protect the kidneys
Renal risk is driven largely by perfusion and prostaglandin effects rather than stomach contents.
Common adverse effects
Vomiting, diarrhea, appetite loss and lethargy are practical early warning signs.
Why appetite loss should be taken seriously
Reduced appetite can precede overt GI bleeding and may be the first clue that treatment is not being tolerated.
Why vomiting matters
Repeated vomiting can worsen dehydration and increase kidney risk.
Why diarrhea matters
Persistent diarrhea increases fluid loss and may signal GI irritation.
Why black stool matters
Melena can indicate upper-GI bleeding and requires prompt veterinary assessment.
Why blood in vomit matters
Fresh blood or coffee-ground material is not a routine side effect to watch at home.
Why severe abdominal pain matters
Guarding, restlessness or collapse can indicate significant GI injury or another acute disease.
Why kidney injury can occur
NSAIDs can reduce protective prostaglandin support of renal blood flow, especially in volume-depleted dogs.
Why dehydration is such an important risk factor
Vomiting, diarrhea, fever, heat exposure or poor drinking can make the kidneys more dependent on prostaglandin-mediated blood flow.
Why surgery can temporarily alter kidney risk
Anesthesia, blood pressure changes and perioperative fluid balance influence renal perfusion.
Why the surgical team needs the last deracoxib dose
This prevents accidental NSAID stacking and helps plan perioperative analgesia safely.
Why heart disease matters
Dogs with heart disease may already have altered renal perfusion and be receiving diuretics or ACE inhibitors.
Why diuretics matter
They can reduce circulating volume and increase renal vulnerability.
Why ACE inhibitors matter
They alter renal hemodynamics and deserve review when NSAIDs are used.
Why liver health matters
NSAID adverse effects can include hepatic injury in susceptible dogs, even though the exact risk varies by molecule.
Why baseline bloodwork helps
Kidney and liver testing provides a reference and can identify dogs with reduced reserve before long-term therapy.
Why follow-up testing can be valuable
Senior dogs and chronic users may develop changes that are not obvious from behavior alone.
Why one normal result does not guarantee future safety
Acute illness or idiosyncratic reactions can change risk after treatment begins.
Why prednisone and deracoxib should not overlap casually
NSAID-steroid combinations substantially increase GI ulcer and bleeding risk.
Why another NSAID should not be added
Carprofen, meloxicam, firocoxib, aspirin and ibuprofen all add overlapping anti-inflammatory risk.
Why aspirin deserves special mention
Its platelet and GI effects can persist beyond the last dose and complicate a switch.
Why human ibuprofen and naproxen are unsafe substitutes
These drugs can cause severe poisoning in dogs.
Why switching from another NSAID needs a plan
Veterinarians may recommend a washout interval to reduce overlapping pharmacologic effects.
Why there is no single universal washout interval
Drug half-life, treatment duration, GI history and urgency differ among patients.
Why non-NSAID pain support may bridge a transition
Gabapentin, amantadine, opioids, rehabilitation and home adaptation can maintain comfort while an NSAID is withheld.
Why gabapentin does not replace anti-inflammatory action
It has a different analgesic mechanism and may be complementary rather than interchangeable.
Why amantadine may be added in chronic pain
Its NMDA-related effects can support multimodal pain treatment in selected dogs.
Why opioid use may be more important after surgery
Acute surgical pain may require stronger short-term analgesia than an NSAID alone provides.
Why medication choice after surgery depends on hydration and blood pressure
NSAIDs may be delayed or withheld if renal perfusion is uncertain.
Why vomiting after surgery needs context
Anesthesia, opioids, pain and NSAIDs can all contribute to nausea, so the cause should be assessed rather than assumed.
Why pain can look like agitation
Restlessness, panting and inability to settle after surgery can reflect inadequate analgesia rather than anxiety alone.
Why increasing deracoxib without advice is unsafe
Extra NSAID exposure raises toxicity risk and may not address the actual cause of pain.
Why sudden lameness needs examination
A dog with chronic arthritis can still rupture a cruciate ligament or fracture a bone.
Why spinal disease can mimic joint pain
Back or nerve-root pain may require different medication and imaging.
Why cancer can mimic arthritis
Persistent focal lameness in an older dog should not automatically be treated by simply escalating NSAIDs.
Why weight management improves analgesic success
Reducing excess load on joints can improve mobility and lower medication demand.
Why rehabilitation matters
Strength and controlled movement help maintain function that medication alone cannot restore.
Why home traction matters
Non-slip flooring reduces muscle tension and fall risk in weak arthritic dogs.
Why nail care matters
Overgrown nails alter paw placement and can worsen traction problems.
Why treatment success should be measured by daily function
Track rising, stairs, walking, sleep and willingness to participate in normal activities.
Why response diaries are useful
They help distinguish a gradual decline from a sudden new injury and make rechecks more objective.
Why owners should know the stop signs
Vomiting, diarrhea, appetite loss, black stool, unusual lethargy or major thirst/urination changes should trigger a call.
Why missed doses should not be doubled
See Missed Dose.
Why accidental double dosing requires prompt advice
See Double Dose.
Why an entire bottle ingestion is an emergency
Large overdoses can cause severe GI and kidney injury and may require decontamination and hospitalization.
Why emergency clinics need the original bottle
The strength and number of missing tablets guide toxicology decisions.
When urgent care is appropriate
Collapse, blood in vomit, black stool, severe abdominal pain, very pale gums, inability to urinate or suspected major overdose requires immediate assessment.
What owners should track
- dose and time;
- food intake;
- vomiting or diarrhea;
- stool color;
- water intake and urination;
- mobility and pain;
- other NSAIDs or steroids;
- recent illness or dehydration.
How this page fits DogMedsHub
This is the main medication page for deracoxib. Class-wide risk remains on NSAID Safety for Dogs and arthritis context remains on Arthritis in Dogs.
The FDA guidance on pain relievers for pets emphasizes using veterinary NSAIDs only under professional direction and avoiding concurrent NSAIDs or corticosteroids.
Why deracoxib treatment should begin with a defined pain goal
For osteoarthritis, the goal may be easier rising and longer comfortable walks. After surgery, the goal may be restful recovery, normal eating and safe movement. Different goals make treatment easier to evaluate.
Why post-operative dosing deserves extra caution
Dogs may be dehydrated, hypotensive or still affected by anesthesia immediately after surgery, all of which can change NSAID safety.
Why perioperative fluids do not make every dog automatically safe for NSAIDs
Fluid therapy supports circulation, but kidney disease, blood pressure and procedure-related blood loss still matter.
Why the first post-operative meal is informative
A dog that refuses food, vomits or appears nauseated may need its analgesic plan reassessed before another oral NSAID dose.
Why pain after surgery can exceed what an NSAID can cover
Major orthopedic or abdominal procedures often require opioids, local anesthetics or other agents in addition to deracoxib.
Why a dog that is quiet is not necessarily comfortable
Sedatives and residual anesthesia can suppress movement while pain remains significant. Pain should be judged by posture, breathing, appetite and response to handling.
Why orthopedic recovery needs controlled activity even when pain relief is good
Medication can make a dog feel ready to run before bone, ligaments or surgical repairs are healed.
Why owner compliance with activity restriction matters
Reinjury can create new pain that is mistakenly interpreted as inadequate medication.
Why long-term arthritis users need weight monitoring
Weight gain increases joint load; weight loss may indicate chronic illness or poor appetite from medication.
Why a stable body condition helps dose consistency
Large changes in body weight can make an old tablet plan inappropriate.
Why a good response can sometimes reveal hidden pain history
Owners may notice renewed play, easier rising or better sleep only after adequate analgesia begins, showing that the dog had adapted quietly to chronic discomfort.
Why apparent tolerance for months does not eliminate future risk
Acute dehydration, new kidney disease or a new interacting medication can change safety suddenly.
Why diarrhea from another cause still matters
Even if deracoxib did not cause the diarrhea, fluid loss can make continued NSAID use riskier.
Why heat illness is relevant
Heat stress causes dehydration and kidney perfusion changes, which can increase NSAID risk.
Why anesthesia history should be shared with every clinic
If another procedure is needed, the team must know the dog is receiving deracoxib before adding injectable anti-inflammatory medication.
Why medication reconciliation prevents duplicate NSAIDs
Emergency clinics may prescribe carprofen or meloxicam unless recent deracoxib use is clearly documented.
Why over-the-counter aspirin should never be added for breakthrough pain
Aspirin adds GI and platelet effects and complicates any future switch to another NSAID.
Why topical human pain creams are also dangerous
Dogs can lick diclofenac or other NSAIDs from an owner’s skin or chew the tube, creating unexpected exposure.
Why pet sitters need to know about interaction rules
They should be told explicitly not to give ibuprofen, naproxen, aspirin or prednisone unless the veterinarian has directed it.
Why urine changes can be an early clue
Markedly reduced urination, increased thirst or accidents can point toward kidney or systemic disease and deserve review.
Why urinalysis can complement bloodwork
Urine concentration helps interpret renal function and hydration in chronic NSAID users.
Why GI protectants are not routine insurance
Omeprazole or sucralfate may be appropriate in selected cases, but they do not make unsafe combinations acceptable and should not be added automatically.
Why long-term use should have periodic benefit review
If mobility is no better after an adequate trial, continuing exposure simply because the bottle was prescribed does not make sense.
Why switching may be reasonable after poor response
Some dogs respond better to another NSAID or another analgesic class, provided the transition is planned safely.
Why rehabilitation should begin before severe muscle loss
Maintaining strength and balance can preserve mobility and reduce the amount of analgesia needed later.
Why quality of life should be documented
Sleep, appetite, willingness to walk, social interaction and ability to toilet comfortably are useful outcomes for long-term treatment decisions.
Why deracoxib should be reconsidered after major health changes
New kidney disease, heart failure, chronic vomiting or steroid treatment can make a previously reasonable NSAID plan unsuitable.
Why the safest pain plan is dynamic
Medication should evolve with the dog’s age, disease and function rather than remain unchanged indefinitely.
Why deracoxib use should be revisited after any hospitalization
A hospital stay can introduce dehydration, new kidney values, new medications or steroid exposure that changes the safety of restarting the previous NSAID. The discharge plan should state clearly whether deracoxib is to continue, pause or stop.
Why postoperative diarrhea still matters even if it began after antibiotics
The exact cause may be uncertain, but fluid loss can increase renal vulnerability. The veterinarian should decide whether continuing the NSAID is appropriate while the GI problem is active.
Why long-term users should have the medication list reviewed at every visit
New heart, kidney, allergy or behavior drugs can change the risk profile over time even when deracoxib itself has been tolerated for months.
Last reviewed: October 2026. Educational information only; deracoxib should be used according to a veterinarian’s individualized pain and monitoring plan.
